ARTICLE | Clinical News
Xyrem sodium oxybate regulatory update
December 12, 2005 8:00 AM UTC
Jazz Pharmaceuticals Inc., Palo Alto, Calif. Product: Xyrem sodium oxybate Business: Neurology EC granted marketing approval of Xyrem sodium oxybate to treat cataplexy associated with narcolepsy. UCB...